Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-21-000048

Options or other derivatives

  • Director acquired 10,473 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Scadden David · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-05-20 Grant or award : show line 1 in the form Restricted stock unit +1,585 1,585 D
2021-05-20 Grant or award : show line 2 in the form Stock options (right to buy) +8,888 8,888 D
Loading xslF345X03/wf-form4_162188914901072.xml…